Nutraceuticals as new treatment approaches for oral cancer: II. Green tea extracts and resveratrol

Oral Oncology

Volumn 49, Issue 6, 2013, Pages 502-506

  Zlotogorski, Ayelet ^a,b   Dayan, Aliza ^c   Dayan, Dan ^b   Chaushu, Gavriel ^a,b   Salo, Tuula ^d,e   Vered, Marilena ^b,f  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Natural Health Science   (Israel)

^d UNIVERSITY OF OULU   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f SHEBA MEDICAL CENTER   (Israel)

Author keywords

Anti cancer activity; Bioavailability; Green tea extracts; Nanotechnology; Nutraceuticals; Oral cancer; Resveratrol

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; PROTEIN BCL 2; PROTEIN BCL XL; RESVERATROL; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CELL PROLIFERATION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STABILITY; ENCAPSULATION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; IN VITRO STUDY; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ANIMALS; CATECHIN; DIETARY SUPPLEMENTS; HUMANS; MICE; MOUTH NEOPLASMS; PLANT EXTRACTS; STILBENES; TEA;

EID: 84877022688     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.02.011     Document Type: Review

References (59)

1. S.C. Gupta, J.H. Kim, S. Prasad, and B.B. Aggarwal Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals Cancer Metastasis Rev 29 3 2010 405 434
2. M.A. Rahman, A.R. Amin, and D.M. Shin Chemopreventive potential of natural compounds in head and neck cancer Nutr Cancer 62 7 2010 973 987
3. N.F. Saba, A. Hammond, D.M. Shin, and F.R. Khuri Moving toward bioadjuvant approaches to head and neck cancer prevention Int J Radiat Oncol Biol Phys 69 2 Suppl 2007 S132 S135
4. A. Zlotogorski, A. Dayan, D. Dayan, G. Chaushu, T. Salo, and M. Vered Nutraceuticals as new treatment approaches for oral cancer - I: Curcumin Oral Oncol 49 3 2013 187 191
5. S. Warnakulasuriya Global epidemiology of oral and oropharyngeal cancer Oral Oncol 45 4-5 2009 309 316
6. B.N. Singh, S. Shankar, and R.K. Srivastava Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications Biochem Pharmacol 82 12 2011 1807 1821
7. C. Cabrera, R. Artacho, and R. Giménez Beneficial effects of green tea-a review J Am Coll Nutr 25 2 2006 79 99
8. H.B. Nair, B. Sung, V.R. Yadav, R. Kannappan, M.M. Chaturvedi, and B.B. Aggarwal Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer Biochem Pharmacol 80 2010 1833 1843
9. J.L. Italia, P. Datta, D.D. Ankola, and M.N.V.R. Kumar Nanoparticles enhance per oral bioavailability of poorly available molecules: epigallocatechin gallate nanoparticles ameliorates cyclosporine induced nephrotoxicity in rats at three times lower dose than oral solution J Biomed Nanotechnol 4 2008 304 312
10. T.G. Shutava, S.S. Balkundi, P. Vangala, J.J. Steffan, R.L. Bigelow, and J.A. Cardelli Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols ACS Nano 3 2009 1877 1885
11. I.A. Siddiqui, V.M. Adhami, D.J. Bharali, B.B. Hafeez, M. Asim, and S.I. Khwaja Introducing nanochemoprevention as a novel approach for cancer control proof of principle with green tea polyphenol epigallocatechin-3-gallate Cancer Res 69 2009 1712 1716
12. T.M. Elattar, and A.S. Virji Effect of tea polyphenols on growth of oral squamous carcinoma cells in vitro Anticancer Res 20 5B 2000 3459 3465
13. Y.C. Lim, S.H. Lee, M.H. Song, K. Yamaguchi, J.H. Yoon, and E.C. Choi Growth inhibition and apoptosis by (-)-epicatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells Eur J Cancer 42 18 2006 3260 3266
14. A. Khafif, S.P. Schantz, M. Al-Rawi, D. Edelstein, and P.G. Sacks Green tea regulates cell cycle progression in oral leukoplakia Head Neck 20 6 1998 528 534
15. M. Masuda, M. Suzui, and I.B. Weinstein Effects of epigallocatechin-3- gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines Clin Cancer Res 7 12 2001 4220 4229
16. T. Yamamoto, H. Digumarthi, Z. Aranbayeva, J. Wataha, J. Lewis, and R. Messer EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase Toxicol Appl Pharmacol 224 3 2007 318 325
17. H.Y. Lin, S.C. Hou, S.C. Chen, M.C. Kao, C.C. Yu, and S. Funayama (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells J Agric Food Chem 60 10 2012 2480 2489
18. D. Yu, and M.C. Hung Overexpression of ErbB2 in cancer and ErbB2-targeting strategies Oncogene 19 53 2000 6115 6121
19. M. Masuda, M. Suzui, J.T. Lim, and I.B. Weinstein Epigallocatechin-3- gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells Clin Cancer Res 9 9 2003 3486 3491
20. K.K. Ang, B.A. Berkey, X. Tu, H.Z. Zhang, R. Katz, and E.H. Hammond Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 24 2002 7350 7356
21. M. Masuda, M. Suzui, J.T. Lim, A. Deguchi, J.W. Soh, and I.B. Weinstein Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction J Exp Ther Oncol 2 6 2002 350 359
22. M.R. Sartippour, D. Heber, L. Zhang, P. Beatty, D. Elashoff, and R. Elashoff Inhibition of fibroblast growth factors by green tea Int J Oncol 21 2002 487 491
23. M.R. Sartippour, Z.M. Shao, D. Heber, P. Beatty, L. Zhang, and C. Liu Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells J Nutr 132 2002 2307 2311
24. S. Lamy, D. Gingras, and R. Beliveau Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation Cancer Res 62 2002 381 385
25. J. McLarty, R.L. Bigelow, M. Smith, D. Elmajian, M. Ankem, and J.A. Cardelli Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro Cancer Prev Res (Phila) 2 2009 673 682
26. D. Bourboulia, and W.G. Stetler-Stevenson Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion Semin Cancer Biol 20 3 2010 161 168
27. G. Geletu, P. Plamadeala, D. Gogalniceanu, H.F. Zeilhofer, E. Popescu, and M. Moscalu Urokinase-type plasminogen activator (uPA) and its inhibitor-new prognostic factors in oral squamous cell carcinoma Rev Med Chir Soc Med Nat Iasi 108 1 2004 79 84
28. Y.C. Ho, S.F. Yang, C.Y. Peng, M.Y. Chou, and Y.C. Chang Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator J Oral Pathol Med 36 10 2007 588 593
29. P.N. Chen, S.C. Chu, W.H. Kuo, M.Y. Chou, J.K. Lin, and Y.S. Hsieh Epigallocatechin-3 gallate inhibits invasion, epithelial-mesenchymal transition, and tumor growth in oral cancer cells J Agric Food Chem 59 8 2011 3836 3844
30. K. Kato, N.K. Long, H. Makita, M. Toida, T. Yamashita, and D. Hatakeyama Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells Br J Cancer 99 4 2008 647 654
31. Y.W. Koh, E.C. Choi, S.U. Kang, H.S. Hwang, M.H. Lee, and J. Pyun Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met J Nutr Biochem 22 11 2011 1074 1083
32. K.H. Jung, B.H. Park, and S.S. Hong Progress in cancer therapy targeting c-Met signaling pathway Arch Pharm Res 35 4 2012 595 604
33. W.C. Chiang, Y.K. Wong, S.C. Lin, K.W. Chang, and C.J. Liu Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin-3- gallate suppress MMP-13 expression Oral Dis 12 1 2006 27 33
34. C.W. Cheng, P.C. Shieh, Y.C. Lin, Y.J. Chen, Y.H. Lin, and D.H. Kuo Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells J Agric Food Chem 58 2010 887 894
35. A. Khafif, S.P. Schantz, T.C. Chou, D. Edelstein, and P.G. Sacks Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells Carcinogenesis 19 1998 419 424
36. A.R. Amin, F.R. Khuri, Z.G. Chen, and D.M. Shin Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-{kappa}B Cancer Prev Res (Phila Pa) 2 6 2009 538 545
37. S.K. Mantena, S.M. Meeran, C.A. Elmets, and S.K. Katiyar Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors J Nutr 135 2005 2871 2877
38. S. Katiyar, C.A. Elmets, and S.K. Katiyar Green tea and skin cancer: photoimmunology, angiogenesis and DNA repair J Nutr Biochem 18 2007 287 296
39. N. Li, X. Chen, J. Liao, G. Yang, S. Wang, and Y. Josephson Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin Carcinogenesis 23 2002 1307 1313
40. X. Zhang, H. Zhang, M. Tighiouart, J.E. Lee, H.J. Shin, and F.R. Khuri Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor Int J Cancer 123 5 2008 1005 1014
41. K.M. Pisters, R.A. Newman, B. Coldman, D.M. Shin, F.R. Khuri, and W.K. Hong Phase I trial of oral green tea extract in adult patients with solid tumors J Clin Oncol 19 2001 1830 1838
42. N. Li, Z. Sun, C. Han, and J. Chen The chemopreventive effects of tea on human oral precancerous mucosa lesions Proc Soc Exp Biol Med 220 1999 218 224
43. A.S. Tsao, D. Liu, J. Martin, X.M. Tang, J.J. Lee, and A.K. El-Naggar Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions Cancer Prev Res (Phila Pa) 2 2009 931 941
44. B.B. Aggarwal, A. Bhardwaj, R.S. Aggarwal, N.P. Seeram, S. Shishodia, and Y. Takada Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies Anticancer Res 24 2004 2783 2840
45. P. Kopp Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol 138 1998 619 620
46. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493 506
47. A. Bishayee Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials Cancer Prev Res (Phila) 2 2009 409 418
48. T.M. ElAttar, and A.S. Virji Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation Anticancer Drugs 10 1999 187 193
49. A. Tyagi, M. Gu, T. Takahata, B. Frederick, C. Agarwal, and S. Siriwardana Resveratrol selectively induces DNA damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma Clin Cancer Res 17 2011 5402 5411
50. T. Walle, F. Hsieh, M.H. DeLegge, J.E. Oatis Jr., and U.K. Walle High absorption but very low bioavailability of oral resveratrol in humans Drug Metab Dispos 32 2004 1377 1382
51. D.M. Goldberg, J. Yan, and G.J. Soleas Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clin Biochem 36 2003 79 87
52. D.J. Boocock, G.E. Faust, K.R. Patel, A.M. Schinas, V.A. Brown, and M.P. Ducharme Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent Cancer Epidemiol Biomark Prev 16 2007 1246 1252
53. K. Teskac, and J. Kristl The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol Int J Pharm 390 2010 61 69
54. J. Shao, X. Li, X. Lu, C. Jiang, Y. Hu, and Q. Li Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels Colloids Surf B Biointerf 72 2009 40 47
55. M. Vered, D. Dayan, and T. Salo The role of the tumour microenvironment in the biology of head and neck cancer: lessons from mobile tongue cancer Nat Rev Cancer 11 5 2011 382
56. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
57. Ghiringhelli F, Rébé C, Hichami A, Delmas D. Immunomodulation and anti-inflammatory roles of polyphenols as anticancer agents. Anticancer Agents Med Chem 2012. [Epub ahead of print].
58. Y. Yang, J.H. Paik, D. Cho, J.A. Cho, and C.W. Kim Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells Int Immunopharmacol 8 2008 542 547
59. Y.J. Choi, K.M. Yang, S.D. Kim, Y.H. Yoo, S.W. Lee, and S.Y. Seo Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells Exp Ther Med 3 2012 592 598